Results 191 to 200 of about 2,753,395 (319)

Preoperative cell-mediated immune status of gastric cancer patients [PDF]

, 1976
Kunzo Orita, Hiroaki Miwa, Hanzo Fukuda, Masahito Yumura, Yoshio Uchida, Tetsuya Mamnami, Eiji KONAGA, Sanae Tanaka   +7 more
openalex   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

Regulation of angiogenesis and cancer cell proliferation by human vault RNA1-2. [PDF]

NAR Cancer
Gallo S, Suspitsyna A, Sanchez-Taltavull D, Fort RS, Duhagon MA, Stroka D, Polacek N.   +6 more
europepmc   +1 more source

A bioinformatics screen identifies TCF19 as an aggressiveness‐sustaining gene in prostate cancer

Molecular Oncology, EarlyView.
Gene expression meta‐analysis in multiple prostate cancer patient cohorts identifies Transcription factor 19 (TCF19) as an aggressiveness‐sustaining gene with prognostic potential. TCF19 is a gene repressed by androgen signaling that sustains core cancer‐related processes such as vascular permeability or tumor growth and metastasis.
Amaia Ercilla, Jana R. Crespo, Saioa Garcia‐Longarte, Marta Fidalgo, Sara del Palacio, Natalia Martin‐Martin, Onintza Carlevaris, Ianire Astobiza, Sonia Fernández‐Ruiz, Marc Guiu, Laura Bárcena, Isabel Mendizabal, Ana M. Aransay, Mariona Graupera, Roger R. Gomis, Arkaitz Carracedo   +15 more
wiley   +1 more source

ZBTB7A regulates CD95-mediated cell growth in colorectal cancer cell lines. [PDF]

PLoS One
Bie Y, Bie M, Liu W, Tao S, Xing H, Kuang L, Song Y.   +6 more
europepmc   +1 more source

A Study on the Sensitivity Test of Cancer Cells to Anticancer Drugs

, 1966
M Fukushima, Yoshinobu Ishikawa, T Horimai, Minoru Adachi   +3 more
openalex   +2 more sources

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

Molecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici, Soheil Akbari, Ceyda Caliskan, Canan Celiker, Ozden Oz, Leman Binokay, Gökhan Karakulah, Serif Senturk, Esra Erdal   +8 more
wiley   +1 more source

CELL PROLIFERATION OF EARLY GASTRIC CANCER

, 1968
K Shichijo, H. Suto, Jiro Kobayashi, Ichiro Ooki, Minoru Tukada, Toshikazu Sekiguchi, Tugio Higuchi   +6 more
openalex   +2 more sources

Primary liver cell cancer in Britain--a viral aetiology? [PDF]

, 1979
M.F. Bassendine, R. G. Chadwick, T Lyssiotis, Howard C. Thomas, Sheila Sherlock, B J Cohen   +5 more
openalex   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source